The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Share News (IPO)

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 49.40
Bid: 48.90
Ask: 49.15
Change: -0.15 (-0.30%)
Spread: 0.25 (0.511%)
Open: 49.30
High: 49.40
Low: 49.30
Prev. Close: 49.55
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IP Group net asset value declines amid supply chain issues, inflation

Wed, 13th Mar 2024 11:02

(Alliance News) - IP Group PLC on Wednesday reported a slowed decline in net asset value, citing global issues such as supply chain disruptions and inflation and interest rate trends.

IP Group invests in companies pursuing breakthrough science and innovation, such as Oxford Nanopore Technologies PLC.

The company said net asset value per share declined 14% to 114.8 pence as at December 31 from 132.9p a year prior.

The contraction on return on NAV was 13% in 2023, compared to a decline of 20% in 2022.

Pretax loss narrowed 49% to GBP176.3 million from GBP343.5 million.

"We continue to monitor the impact of the ongoing wars in Ukraine and the Middle East, heightened geopolitical tension, supply chain disruption, inflation and interest rate trends, elevated levels of the cost of living and volatile capital markets," IP Group said. and note

It added that "the greatest impact to the group has been the marked decline in the valuation of technology and life sciences sector listed companies, which we consider heighten our principal risks of macroeconomic environment and access to capital risks."

The company proposed a final dividend to 0.76 pence per share, upped from 0.72p a year prior. This brought the total for 2023 to 1.27p, up 4.1% from 1.22p.

Looking ahead, IP Group cited opportunities to benefit from increased public policy support in the UK for science and innovation, with GBP109 million capital across the company's third party managed funds including its subsidiary Parkwalk Advisors.

Chief Executive Officer Greg Smith said: "The group and its portfolio remain well-funded and we are confident the group will reap the benefits of our maturing portfolio given the number of key milestones anticipated over the next 12 to 18 months, particularly in life sciences.

"The group is committed to delivering value for all stakeholders and anticipates that the next 18 months could be transformational to fair value growth."

IP Group shares fell 2.3% to 50.40 pence each on Wednesday morning in London.

By Tom Budszus, Alliance News slot editor

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
27 Jul 2021 12:07

IP Group's Artios raises USD153 million for cancer therapy pipeline

IP Group's Artios raises USD153 million for cancer therapy pipeline

Read more
27 Jul 2021 09:18

IP Group portfolio company completes Series C financing

(Sharecast News) - Intellectual property-based business investor IP Group said on Tuesday that portfolio company Artios Pharma had completed a $153.0m Series C financing to fund the further development of its clinical-stage pipeline.

Read more
28 Jun 2021 13:41

IN BRIEF: IP Group Non-Exec Director Hynes buys 21,000 shares

IN BRIEF: IP Group Non-Exec Director Hynes buys 21,000 shares

Read more
17 Jun 2021 09:48

IP Group investee Apollo Therapeutics completes USD145 million raise

IP Group investee Apollo Therapeutics completes USD145 million raise

Read more
17 Jun 2021 07:40

IP Group portfolio business raises $145m in financing round

(Sharecast News) - Intellectual property business IP Group said on Thursday that portfolio company Apollo Therapeutics had completed a $145.0m financing round.

Read more
9 Jun 2021 16:08

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
9 Jun 2021 14:27

IN BRIEF: IP Group invests GBP250,000 in GBP1.1 million Itaconix raise

IN BRIEF: IP Group invests GBP250,000 in GBP1.1 million Itaconix raise

Read more
9 Jun 2021 09:21

IN BRIEF: IP Group expects GBP80 million in first half realisations

IN BRIEF: IP Group expects GBP80 million in first half realisations

Read more
9 Jun 2021 08:01

IP Group preparing for first divi as portfolio progress continues

(Sharecast News) - Intellectual property business developer IP Group said on Wednesday that for the year to date, its positive progress made by many of its portfolio companies in 2020 had continued.

Read more
7 Jun 2021 09:24

IP Group sells part of Iksuda Therapeutics stake in financing round

IP Group sells part of Iksuda Therapeutics stake in financing round

Read more
7 Jun 2021 07:25

IP Group portfolio co Iksuda raises £42m to develop cancer drug

(Sharecast News) - Intellectual property business developer IP Group said its portfolio company Iksuda Therapeutics had completed a $42m (£29m) financing round to fund human clinical trials of its lead cancer drug.

Read more
2 Jun 2021 15:55

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
28 May 2021 15:12

IP Group launches joint venture aiming to provide capital in China

IP Group launches joint venture aiming to provide capital in China

Read more
27 May 2021 13:25

TRADING UPDATES: Savills brings in Samsung Life as unit investor

TRADING UPDATES: Savills brings in Samsung Life as unit investor

Read more
17 May 2021 14:06

IP Group gains GBP20 million after portfolio company sale

IP Group gains GBP20 million after portfolio company sale

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.